Evidence map›Paper›PMID 26013481›Full record

ArticleJournal of bacteriology2015

Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075.

Kyle A Tipton, Daniela Dimitrova, Philip N Rather

Abstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Disruption ofVirulence · 2026
    Article
  2. Loss of CsrA inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Phenylacetic acid mediatesMicrobiology (Reading, England) · 2026
    Article
  8. Article
  9. IntracellularProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kyle A TiptonDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Daniela DimitrovaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Philip N RatherDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA Research Service, Atlanta VA Medical Center, Decatur, Georgia, USA prather@emory.edu.

Funding

Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Phase variable control of Acinetobacter baumannii virulenceR21AI115183 · NIAID · EMORY UNIVERSITY · PI RATHER, PHILIP N. · 2015 to 2016
$350k
NIAID NIH HHS 1R21AI115183NIAID NIH HHS R01 AI072219NIAID NIH HHS R21 AI115183
6 · The paper itself

Abstract

unlabelledAcinetobacter baumannii strain AB5075 produces colonies with two opacity phenotypes, designated opaque and translucent. These phenotypes were unstable and opaque and translucent colony variants were observed to interconvert at high frequency, suggesting that a phase-variable mechanism was responsible. The frequency of phase variation both within colonies and in broth cultures increased in a cell density-dependent manner and was mediated by the accumulation of an extracellular factor. This factor was distinct from the known A. baumannii signaling molecule 3-OH C12-homoserine lactone. Opaque and translucent colony variants exhibited a number of phenotypic differences, including cell morphology, surface motility, biofilm formation, antibiotic resistance, and virulence in a Galleria mellonella model. Additional clinical isolates exhibited a similar phase-variable control of colony opacity, suggesting that this may be a common feature of A. baumannii. IMPORTANCE: A novel phase-variable mechanism has been identified in Acinetobacter baumannii that results in an interconversion between opaque and translucent colony phenotypes. This phase variation also coordinately regulates motility, cell shape, biofilm formation, antibiotic resistance, and virulence. The frequency of phase variation is increased at high cell density via a diffusible extracellular signal. To our knowledge, this report presents the first example of phase variation in A. baumannii and also the first example of quorum sensing-mediated control of phase variation in a bacterium. The findings are important, as this phase-variable mechanism can be identified only via changes in colony opacity using oblique light; therefore, many researchers studying A. baumannii may unknowingly be working with different colony variants.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBiofilmsDrug Resistance, BacterialGene Expression Regulation, BacterialPhenotypeVirulenceAnti-Bacterial Agents

Identifiers

PMID26013481
PMCPMC4518826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.